363 related articles for article (PubMed ID: 29178961)
1. The unrecognized occupational relevance of the interaction between engineered nanomaterials and the gastro-intestinal tract: a consensus paper from a multidisciplinary working group.
Pietroiusti A; Bergamaschi E; Campagna M; Campagnolo L; De Palma G; Iavicoli S; Leso V; Magrini A; Miragoli M; Pedata P; Palombi L; Iavicoli I
Part Fibre Toxicol; 2017 Nov; 14(1):47. PubMed ID: 29178961
[TBL] [Abstract][Full Text] [Related]
2. An integrated methodology for assessing the impact of food matrix and gastrointestinal effects on the biokinetics and cellular toxicity of ingested engineered nanomaterials.
DeLoid GM; Wang Y; Kapronezai K; Lorente LR; Zhang R; Pyrgiotakis G; Konduru NV; Ericsson M; White JC; De La Torre-Roche R; Xiao H; McClements DJ; Demokritou P
Part Fibre Toxicol; 2017 Oct; 14(1):40. PubMed ID: 29029643
[TBL] [Abstract][Full Text] [Related]
3. Do Engineered Nanomaterials Affect Immune Responses by Interacting With Gut Microbiota?
Tang M; Li S; Wei L; Hou Z; Qu J; Li L
Front Immunol; 2021; 12():684605. PubMed ID: 34594323
[TBL] [Abstract][Full Text] [Related]
4. New frontiers in nanotoxicology: Gut microbiota/microbiome-mediated effects of engineered nanomaterials.
Pietroiusti A; Magrini A; Campagnolo L
Toxicol Appl Pharmacol; 2016 May; 299():90-5. PubMed ID: 26723910
[TBL] [Abstract][Full Text] [Related]
5. Transformation of Nanomaterials and Its Implications in Gut Nanotoxicology.
Setyawati MI; Zhao Z; Ng KW
Small; 2020 Sep; 16(36):e2001246. PubMed ID: 32495486
[TBL] [Abstract][Full Text] [Related]
6. Current state of knowledge on the health effects of engineered nanomaterials in workers: a systematic review of human studies and epidemiological investigations.
Schulte PA; Leso V; Niang M; Iavicoli I
Scand J Work Environ Health; 2019 May; 45(3):217-238. PubMed ID: 30653633
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity of Engineered Nanomaterials: Testing Considerations.
Scarcello E; Sofranko A; Wahle T; Schins RPF
Front Public Health; 2022; 10():904544. PubMed ID: 35910929
[TBL] [Abstract][Full Text] [Related]
8. Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents.
Bunderson-Schelvan M; Holian A; Hamilton RF
J Toxicol Environ Health B Crit Rev; 2017; 20(4):230-248. PubMed ID: 28632040
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment strategies for nanoscale and fine-sized titanium dioxide particles: Recognizing hazard and exposure issues.
Warheit DB; Donner EM
Food Chem Toxicol; 2015 Nov; 85():138-47. PubMed ID: 26362081
[TBL] [Abstract][Full Text] [Related]
10. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
Oberdörster G
J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
[TBL] [Abstract][Full Text] [Related]
11. Potential bioavailability enhancement of bioactive compounds using food-grade engineered nanomaterials: a review of the existing evidence.
Oehlke K; Adamiuk M; Behsnilian D; Gräf V; Mayer-Miebach E; Walz E; Greiner R
Food Funct; 2014 Jul; 5(7):1341-59. PubMed ID: 24752749
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment of engineered nanomaterials and nanotechnologies--a review.
Savolainen K; Alenius H; Norppa H; Pylkkänen L; Tuomi T; Kasper G
Toxicology; 2010 Mar; 269(2-3):92-104. PubMed ID: 20105448
[TBL] [Abstract][Full Text] [Related]
13. Ingested engineered nanomaterials: state of science in nanotoxicity testing and future research needs.
Sohal IS; O'Fallon KS; Gaines P; Demokritou P; Bello D
Part Fibre Toxicol; 2018 Jul; 15(1):29. PubMed ID: 29970114
[TBL] [Abstract][Full Text] [Related]
14. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.
Warheit DB; Borm PJ; Hennes C; Lademann J
Inhal Toxicol; 2007 Jun; 19(8):631-43. PubMed ID: 17510836
[TBL] [Abstract][Full Text] [Related]
15. Simulating Nanomaterial Transformation in Cascaded Biological Compartments to Enhance the Physiological Relevance of In Vitro Dosing Regimes: Optional or Required?
Llewellyn SV; Kämpfer A; Keller JG; Vilsmeier K; Büttner V; Ag Seleci D; Schins RPF; Doak SH; Wohlleben W
Small; 2021 Apr; 17(15):e2004630. PubMed ID: 33475244
[TBL] [Abstract][Full Text] [Related]
16. The impact of nanomaterial characteristics on inhalation toxicity.
Bierkandt FS; Leibrock L; Wagener S; Laux P; Luch A
Toxicol Res (Camb); 2018 May; 7(3):321-346. PubMed ID: 30090585
[TBL] [Abstract][Full Text] [Related]
17. Difficulties in establishing regulations for engineered nanomaterials and considerations for policy makers: avoiding an unbalance between benefits and risks.
Garduño-Balderas LG; Urrutia-Ortega IM; Medina-Reyes EI; Chirino YI
J Appl Toxicol; 2015 Oct; 35(10):1073-85. PubMed ID: 26046543
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Review of the Routes and Forms of Exposure to Engineered Nanomaterials.
Basinas I; Jiménez AS; Galea KS; Tongeren MV; Hurley F
Ann Work Expo Health; 2018 Jul; 62(6):639-662. PubMed ID: 29931230
[TBL] [Abstract][Full Text] [Related]
19. Nanomaterial exposure, toxicity, and impact on human health.
Pietroiusti A; Stockmann-Juvala H; Lucaroni F; Savolainen K
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Sep; 10(5):e1513. PubMed ID: 29473695
[TBL] [Abstract][Full Text] [Related]
20. Workshop report: strategies for setting occupational exposure limits for engineered nanomaterials.
Gordon SC; Butala JH; Carter JM; Elder A; Gordon T; Gray G; Sayre PG; Schulte PA; Tsai CS; West J
Regul Toxicol Pharmacol; 2014 Apr; 68(3):305-11. PubMed ID: 24462629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
